The Patent Finder

Centauri Therapeutics Limited

Also on record
Records under this name other than patents Centauri Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Centauri Therapeutics Limited

PatentTitleStatus Expires Confidence
US 10,190,121Aptamers against EGFR and therapeutic uses thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,422,746Chemically programmable immunity
Term ended
Term ended Jun 22, 2022 · From the USPTO record
Term endedTerm ended Jun 22, 2022From the USPTO record
US 7,645,743Chemically programmable immunity
Term ended
Term ended Sep 19, 2021 · From the USPTO record
Term endedTerm ended Sep 19, 2021From the USPTO record
US 8,236,321Chemically programmable immunity
Term ended
Term ended Jan 2, 2021 · From the USPTO record
Term endedTerm ended Jan 2, 2021From the USPTO record
US 7,850,975Chemically programmable immunity
Term ended
Ended no later than Dec 21, 2020 · From the USPTO record
Term endedEnded no later than Dec 21, 2020From the USPTO record
US 8,263,082Chemically programmable immunity
Term ended
Term ended Dec 21, 2020 · From the USPTO record
Term endedTerm ended Dec 21, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited